InvestorsHub Logo
Followers 15
Posts 717
Boards Moderated 0
Alias Born 08/12/2022

Re: None

Friday, 05/09/2025 4:43:56 PM

Friday, May 09, 2025 4:43:56 PM

Post# of 170
Started to Nibble on some madrigal options late 2025 holding my core position from the 70.00's AKRO shit data makes MDGL more valuable.
Interesting Madrigal and Sagimet doing a single pill combo of their two drugs soon. Does Madrigal take out Sagimet or does a bigger player show up Bill Sibold Deeper pocket BP like LLY Gilead Novo or Novartis can scoop up on SGMT and not even Flinch they have the best looking oral in the space that works wonders with ThR B and GLP1 like Ozempic in combos a blockbuster stand alone first Line F2 F3 & F4 and a blockbuster for combos with GLp1 42% fibrosis reduction vs 0% in placebo.

$MDGL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MDGL News